Trade Summary

1 month ago, Lederman Seth, serving as CEO at Tonix Pharmaceuticals Holding Corp. (TNXP), purchased 15,000 shares at $14.89 per share, for a total transaction value of $223,350.00. Following this transaction, Lederman Seth now holds 19,007 shares of TNXP.

This purchase represents a 374.00% increase in Lederman Seth's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 18, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, meaning the disclosure happened on the same day as the trade.

Tonix Pharmaceuticals Holding Corp. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.